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Previous literature suggests a positive association between history of premenstrual syndrome (PMS) 
and development of postpartum depression (PPD); however, limited evidence has come from 
prospective population-based studies and whether history of depression affects this association is 
unknown. 
Methods 
This study included 5479 women from the 1973-78 cohort of the Australian Longitudinal Study on 
Women’s Health and estimated the association between pre-pregnancy PMS and PPD. Participants 
were followed from 22-27 years in 2000 to 37-42 years in 2015. PMS was collected from a 4-
category Likert-scale reporting on frequency of PMS in the last 12 months (never, rarely, 
sometimes, or often) at the survey preceding an index birth. PPD was ascertained from reports of 
doctor diagnoses for each birth. Relative risks (RRs) and 95% confidence intervals (CIs) were used 
to estimate the association of interest. The role of history of depression was assessed by testing its 
interaction with pre-pregnancy PMS. 
Results  
During 15 years’ follow-up, 15.4% of participating women reported PPD; and 55.1% reported PMS 
(rarely: 17.2%, sometimes: 25.7%, and often: 12.2%). Compared to women who had no PMS 
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before pregnancy, those who rarely had PMS had similar risk of PPD (1.03, 0.82-1.30); whereas 
those who sometimes or often had PMS had significantly higher risk of PPD (1.31, 1.09-1.57 and 
1.51, 1.22-1.87, respectively). History of depression did not affect the association. 
Limitations 
PMS was self-reported. PMS severity was not collected. 
Conclusions 
This large population-based study provides evidence of a dose-response relationship between PMS 
prior to pregnancy and PPD, independent of history of depression. Evidence to date suggests PMS 
has the potential to help identify women at increased risk of PPD before pregnancy. 
Keywords 
Postpartum depression, premenstrual syndrome, risk factor, screening, early identification, 
prevention  
 
1.1 Introduction  
Postpartum depression (PPD) refers to depression that occurs within one year after childbirth 
(Stewart and Vigod, 2016). It affects about 1 in 6 women who give birth in Australia (Woolhouse et 
al., 2012). Women who develop PPD are more likely to develop long-term maternal depression 
(Goodman, 2004; Stewart and Vigod, 2016). PPD may also interfere with breastfeeding, maternal-
infant bonding and partner relationships, and impair emotional and cognitive development in 
children (Viguera, 2018). Given this, early identification of women at increased risk for PPD is of 
great importance (Stowe and Nemeroff, 1995). 
Established risk factors for PPD include a prior history of depression, poor social support, and 
pregnancy/postpartum complications (Ghaedrahmati et al., 2017). A possible risk factor for PPD 
– premenstrual syndrome (PMS) – refers to a variety of physical and emotional symptoms that 
repeatedly occur during the second half of the menstrual cycle (luteal phase) (Casper, 2020). 
Mood swings, irritability, tension, feeling sad or experiencing depression are the common 
emotional manifestations of PMS (Yonkers). Due to the fact that oestrogen and progesterone 
regulate biological systems, neural networks, and behaviours associated with mood, changes in 
the levels of the two hormones may trigger depressive symptoms (Schiller et al., 2016). As the 
abrupt drop in hormonal levels take place in the luteal phase as well as after delivery, women 
who are susceptible to hormonal fluctuations might get both PMS and PPD (Schiller et al., 2016; 
Yonkers et al., 2008). 
In a recent systematic review and meta-analysis (Cao et al., 2020), we concluded that the 
evidence overall supported a positive association between history of PMS and development of 
PPD. A limitation of this review is that many of the included studies were of low-quality, for 
example they used a cross-sectional or case-control design, which can only detect the co-occurrence 
of PMS and PPD. Other cohort studies (Limlomwongse and Liabsuetrakul, 2006; Martini et al., 
2015; Sylvén et al., 2013; Turkcapar et al., 2015; Wang, 2008; Zhang, 2011) have investigated the 
association between pre-pregnancy PMS and PPD, but they are limited by convenience sampling, 
i.e. recruiting participants through the hospital where women delivered their baby, and not 
distinguishing women who develop PPD as their first depressive episode from those who had a 
previous history of depression. In view of the potentially different pathophysiology (Altemus et al., 
2012; Kettunen et al., 2014) and risk factors (Silverman et al., 2017) between PPD with or without a 
prior depression, the association between PMS and PPD may be affected by history of depression. 
However, no studies so far have accounted for this.  
Another drawback of previous studies is the investigation of the association between PMS and 
PPD in only one birth of the participants. A longitudinal cohort that tracks participants over the 
years can capture the development of PPD in more than one birth as well as the changing status of 
PMS and other covariates over time. Using such data may assist in a more thorough examination of 
potential confounders for the association between pre-pregnancy PMS and PPD.  
In this study, we used a prospective cohort of women who were followed up for 15 years from 
22-27 years to 37-42 years to examine the longitudinal association of PMS before pregnancy with 
the risk of PPD development. Our hypothesis was that PMS before pregnancy increases the risk of 
PPD development, and history of depression will affect this association.  
1.2 Material and methods 
1.2.1 Participants and study design  
The 1973-78 cohort of the Australian Longitudinal Study on Women’s Health (ALSWH) formed 
the study population. In 1996, the ALSWH recruited a nationally representative sample of over 
40000 women from the Medicare database in three age cohorts, born in 1921-26, 1946-51 and 
1973-78, and these cohorts have been followed at approximate 3-yearly intervals since then via 
postal and/or online surveys (Lee et al., 2005). The aim of the ALSWH is to examine the social, 
psychological, physical and environmental factors which determine good health, and those which 
cause ill health, in women across the life course, with particular emphasis on women’s access to and 
use of health services. Detailed survey methods have been previously published (Dobson et al., 
2015). The 1973-78 cohort consists of women who were aged 18-23 years in 1996, and up to 2018 
had completed eight surveys.  
For this analysis, data over 15 years from Survey 2 (conducted in 2000 when the women were 
22-27 years) to Survey 7 (in 2015, when 37-42 years) were used. Survey 1 was not included since 
PPD was not collected, and at the time of analysis data from the most recent survey (in 2018) was 
not yet available. Hence, baseline refers to Survey 2 in this analysis. Figure 1 shows the process of 
participant selection, with 5479 women and their 10722 births during the 15 years of follow-up 
included in the analysis. Women included were those who were not pregnant at baseline, had at 
least one live birth between Survey 2 and Survey 7, and had no previous history of PPD. Pre-
pregnancy characteristics, including PMS and other covariates, were collected from the survey 
preceding each birth to analyse the association of interest. For example, if a woman had a child 
between Survey 3 and 4, pre-pregnancy factors collected at Survey 3 were used. If she then had a 
second birth between Survey 6 and 7, pre-pregnancy factors collected at Survey 6 were used.  
1.2.2 Measurements 
All data used were from the women’s self-report. 
Exposure 
The presence of PMS was reported at each survey using the 4-category Likert-scale: “In the last 12 
months, have you had premenstrual tension? (never, rarely, sometimes, or often)”.  
Outcome 
In each of Surveys 5, 6 and 7, the women were asked to retrospectively record whether they had 
PPD following the birth of every child, with the question “Were you diagnosed or treated for 
postnatal depression?” (yes/no). If women did not complete these questions fully for every birth, 
this missing information was able to be inferred for some women using a question that had been 
asked in each of Surveys 2, 3 and 4; “In the last 3 or 4 years, have you been told by a doctor that 
you have postnatal depression?” (yes/no). We were able to use the children’s date of birth, together 
with the date the women completed Surveys 2 to 4 to ascertain whether the women had reported 
PPD for that particular birth. 
Covariates  
The following sociodemographic factors and common risk factors of PMS and PPD were included 
as covariates, which were repeatedly collected at each survey: age, highest qualification (university 
degree or higher, high school/trade/diploma and less than high school), marital status (married/de 
facto and not married/separated/widowed), area of residence (major cities, inner regional and outer 
regional/remote/very remote), ability to manage on income (easy, not too bad, difficult sometimes 
and difficult always/impossible), social support (all of the time, most of the time and some/a 
little/none of the time), body mass index (BMI, <18.5, 18.5 to <25, 25 to <30 and ≥30), physical 
activity (sedentary, low, moderate and high), smoking (never smoker, ex-smoker and current 
smoker), oral contraceptives (OCPs) use (not using and using), and history of depression (based on 
either self-report of doctor-diagnosed depression or use of antidepressants both asked at each 
survey; for both measures women were classified as having a history of depression if they answered 
yes at any preceding survey).  
Age at menarche (≤11, 12-14 and ≥15 years) (Harlow et al., 2004; Mendle et al., 2018), parity 
(primiparous/multiparous) (Di Florio et al., 2014; Iwata et al., 2016), gestational diabetes (yes/no) 
(Arafa and Dong, 2019; Azami et al., 2019) and preterm birth (yes/no) (de Paula Eduardo et al., 
2019; Helle et al., 2015) were also included as covariates since previous literature has reported a 
positive association with depression or PPD. 
1.2.3 Statistical analysis 
Baseline characteristics of the women and univariable associations with prospective development of 
PPD were described and compared using descriptive statistics, chi-square, or t-tests. Relative risks 
(RRs) and 95% confidence intervals (CIs) were used to report the longitudinal association between 
PMS, covariates and PPD, calculated from log-binomial or log-Poisson regression (when the log-
binomial model did not converge) models with generalised estimating equations (GEE) to account 
for the correlation between births of the same woman.  
PPD was regressed on PMS reported in the survey before the index birth, as well as the other 
covariates. First, the longitudinal univariable analysis was performed. Significant factors identified 
from the univariable analysis were included in the multivariable analysis. Statistical significance 
was set at P-value <0.05. Although OCPs use was not significantly associated with PPD in the 
univariable analysis, it was included in the adjusted models because OCPs are commonly used for 
treating PMS (Mayo Clinic) and have been recently reported as being associated with PPD 
development (Horibe et al., 2018; Roberts and Hansen, 2017). The fully adjusted models controlled 
for the following covariates for the index birth: sociodemographic factors (highest qualification, 
marital status and difficulty on managing income), reproductive factors (maternal age, parity, 
gestational diabetes and preterm birth), lifestyle factors (pre-pregnancy BMI, physical activity, 
smoking, and OCPs use), social support, and history of depression. 
To examine whether the association between PMS and PPD was affected by history of 
depression, we tested the interaction between PMS and history of depression by including a product 
term in the fully adjusted model.  
To assess the robustness of the findings, we performed three sensitivity analyses. First, the 
history of doctor-diagnosed depression was replaced with the history of any prior use of 
antidepressants. Second, to assess the influence of participants exclusion due to missing values in 
covariates (n=539), PROC MI was used to impute missing values in PMS, highest qualification, 
marital status, ability to manage income, pre-pregnancy BMI, physical activity, smoking, OCP use, 
and social support. Association between PMS and PPD was assessed in 10 imputed datasets, and 
the effect estimates were then pooled using PROC MIANALYZE. Third, the study sample was 
restricted to primiparous women and their first births. All statistical analysis was conducted using 
SAS 9.4 for Windows (SAS Institute Inc., Cary, NC, USA). 
1.2.4 Ethical approval  
Ethical approvals for the project were granted from the Human Research Ethics Committees of the 
University of Newcastle (Approval No. H-076-0795) and the Medical Research Ethics Committee 
of the University of Queensland (Approval No. 2004000224 and 2012000950). All participants 
gave signed informed consent, and all data used in the analyses were de-identified. 
1.3 Results 
1.3.1 Baseline characteristics, experience of PMS and development of PPD 
Among the 5479 women who had at least one live birth during the 15 years of follow-up, 842 
women (15.4%) reported having PPD in 887 births, and 3019 women (55.1%) reported 
experiencing PMS (rarely: 17.2%, sometimes: 25.7%, and often: 12.2%). PPD was more likely to 
occur in women with less education, who had more difficulty in managing their income, had less 
social support, had a history of depression and who were current smokers at baseline (Table 1). 
1.3.2 Association between pre-pregnancy PMS and PPD 
The univariable association between covariates and PPD are shown in Table S1. Table 2 shows a 
dose-response relationship between pre-pregnancy PMS and PPD after adjustment for all 
covariates. That is, compared to women who had no PMS before pregnancy, those who rarely had 
PMS had similar risk of developing PPD (1.03, 0.82-1.30); those who sometimes had PMS had 
higher risk of PPD (1.31, 1.09-1.57); and those who often had PMS had the highest risk of getting 
PPD (1.51, 1.22-1.87).  
1.3.3 The role of history of depression in the association between PMS and PPD 
No significant interaction was detected between pre-pregnancy PMS and history of depression 
(P-value for interaction: 0.47).  
1.3.4 Summary of sensitivity analyses 
The results of sensitivity analyses are shown in Table S2, which all support a dose-response 
relationship between pre-pregnancy PMS and PPD, except for the non-statistically significant 
increased risk of PPD among primiparous women who sometimes had PMS symptoms before 
pregnancy (1.15, 0.92-1.44). 
1.4 Discussion  
In this longitudinal cohort study from Australia, we evaluated the association between PMS and 
PPD development among 5479 women, who had given birth during the 15 years of follow-up from 
age 22-27 to 37-42 years. We observed that PMS before pregnancy was positively associated with 
PPD in a dose-response fashion, and this relationship was independent of the history of depression.  
1.4.1 Interpretation and comparisons with other studies 
By tracking a nationally representative Australian sample from when they were aged in their 
twenties to early forties, our study was able the capture of occurrences of PMS and PPD as well as 
time-varying covariates over 15 years. This time period covered almost the full length of the 
women’s childbearing years and included all their births during this period. With the application of 
GEE models and autoregressive working correlation, we took account of the correlation between 
repeated births of each woman, as well as the impact of the PPD occurrence on the subsequent 
births. As a result, the population-averaged effect of pre-pregnancy PMS on PPD development was 
estimated.  
The increased risk for PPD observed among women with pre-pregnancy PMS is consistent with 
the finding of a meta-analysis that we recently published, in which we reported that women who 
had PMS before pregnancy had more than double the odds of developing PPD (odds ratio (OR), 
95% CI: 2.20, 1.81–2.68) based on current literature (Cao et al., 2020). Several prospective cohort 
studies have reported similar findings, even though they have only evaluated the association of 
interest in one birth per woman and dichotomised the status of PMS into having or not having 
(Limlomwongse and Liabsuetrakul, 2006; Sylvén et al., 2013; Turkcapar et al., 2015; Wang, 2008; 
Zhang, 2011). For example, a Turkish cohort study including 540 women observed that women 
with a history of PMS had twice the odds of PPD compared to those who had no PMS before 
pregnancy (OR: 2.05, 1.25-2.33) (Turkcapar et al., 2015). A Swedish study led by Sylvén et al. 
measured PPD in 1308 women three times after delivery and found that history of PMS was 
associated with PPD at five days and six weeks after birth (Sylvén et al., 2013).  
The finding that the relationship between PMS and PPD was independent of history of 
depression did not support our hypothesis. This is slightly different to the finding of another study 
led by Sylvén and colleagues (Sylvén et al., 2017), in which they concluded that PMS before 
pregnancy was associated with PPD at five days (crude OR: 3.5, 1.2-10.0) but not at six weeks 
postpartum (crude OR:0.98, 0.1-7.7) in 653 first-time mothers without any previous contact with 
psychiatric services. 
The underlying biological mechanism for the association of PMS and PPD may relate to the role 
of oestrogen and progesterone in mood regulation. Oestrogen and progesterone are involved in 
regulating biological systems, neural networks, and behaviours associated with mood; therefore, 
changes in the level of the two hormones may trigger affective dysregulation and lead to depressive 
symptoms (Schiller et al., 2016). Because the levels of both hormones abruptly drop during the 
luteal phase as well as after delivery, women who are sensitive to hormonal fluctuations could 
experience both PMS and PPD (Schiller et al., 2016; Yonkers et al., 2008). However, for women 
who had a history of PMS but developed PPD in the late postpartum period (the level of hormones 
remains stable at this point), this explanation may not apply. Psychosocial factors, such as external 
stressors may also play a role in the link between pre-pregnancy PMS and PPD development 
(Halbreich, 2005). Future investigations of the theoretical underpinnings of the positive association 
between PMS and PPD are warranted. 
1.4.2 Strengths and limitations  
A unique strength of this present study is the longitudinal study design. This is, to our 
knowledge, the first study to use a longitudinal cohort to investigate the prospective association 
between PMS before pregnancy and development of PPD. As a population-based study, the 
exposure and most covariates were asked at each survey, regardless of whether women were 
planning or not to get pregnant, which to a large extent prevented the selection bias of participants. 
Besides, a comprehensive adjustment for confounders that may have affected the association of 
interest, such as maternal age at birth, parity, pregnancy complications, social support, and history 
of depression, was conducted. In addition, sensitivity analyses, which generated similar results, 
indicated the robustness of our findings. Furthermore, the finding that the association of interest was 
independent of women’s previous history of depression highlighted the biological and/or 
psychosocial link between PMS and PPD. This has implications for the early identification of 
women at risk of PPD based on their history of PMS. Finally, since participants in this study were 
largely nationally representative, our results can be generalised to Australian women of the same 
age. 
Limitations of the present study included at least three aspects. First, for the main analysis, 
identification of PPD was ascertained from women’s self-reports of doctor-diagnosed or treated 
PPD for each birth, which might be slightly different from the current definition of PPD specified in 
the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V) (American 
Psychiatric Association, 2013). Introduced in 2013, the DSM-V required the onset of depressive 
symptoms to occur during pregnancy or within 4 weeks following delivery. Participants in our 
study who had given birth before 2013 (which equated to Surveys 2 to 6) could have been 
diagnosed for PPD with different criteria, especially those who had a late onset of depressive 
symptoms after delivery. However, multiple administrative data sources have shown the accuracy 
of our self-reported PPD measures. We previously found that 63% of our self-reported PPD cases 
had received antidepressants treatment or Medicare-subsidised mental health services in the first 
postpartum year, and 72-75% of the diagnosed cases retrieved from hospital records were correctly 
reported by women in the survey (data on request). The association observed in our study might 
have underestimated the true relationship between pre-pregnancy PMS and PPD risk if 
underreporting of PPD existed. In an additional analysis (Table S3), we used the women’s scores on 
the Mental Health Subscale from the SF-36 within one year of delivery to infer PPD symptoms, 
instead of the doctor diagnosed PPD. Using survival analysis, which accounted for the time from 
birth to when women completed the subscale, we observed a 75% higher risk of PPD for women 
who often experienced PMS before pregnancy (Hazard Ratio: 1.75, 1.19-2.57). This to some extent 
strengthened our findings. 
Second, the experience of PMS was derived from the question asking about premenstrual tension 
retrospectively, which may result in recall bias. Premenstrual tension is the old term defined in the 
International Statistical Classification of Diseases and Related Health Problems, Tenth  Edition 
(ICD-10) describing premenstrual symptoms such as tension or migraine without consideration of 
the type or severity of the symptoms (Pearlstein, 2007). This is broader than the definition of core 
premenstrual disorders specified in recent PMS consensus/guidelines (Nevatte et al., 2013; Royal 
College of Obstetricians & Gynaecologists, 2017; World Health Organization, 2018). Although we 
categorised women into four levels of PMS frequency, the severity of PMS was not measured. 
Third, due to the 3-year interval between two consecutive surveys, PMS history for some women 
might have been up to 3 years before the index pregnancy, but on average, the PMS history was 0.8 
year before the index pregnancy.  
1.4.3 Clinical implications 
Both the Australian (Centre of Perinatal Excellence, 2017) and the US (US Preventive Services 
Task Force, 2019) perinatal mental health guidelines recommend screening for psychosocial risk 
factors of PPD during pregnancy and after delivery to identify women at risk; however, very limited 
factors have been included in these guidelines, including previous history of depression, lack of 
social support and low socioeconomic status. Findings from the present study highlight the potential 
of PMS to identify women at risk of PPD well before they fall pregnant. If the results were to be 
replicated in different populations, a new PPD screening list might be developed in future, 
incorporating PMS history in addition to those socioeconomic and psychiatric factors that are 
currently used to screen women at increased risk of PPD during or after pregnancy (Centre of 
Perinatal Excellence, 2017; US Preventive Services Task Force, 2019). 
1.5 Conclusions  
A dose-response relationship was observed between pre-pregnancy PMS and PPD risk in the 
ALSWH 1973-78 cohort, and the association was independent of the history of depression. The 
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Figure 1. Flowchart of participant selection 
 
  
Table 1. Baseline characteristics of non-pregnant women according to prospective development of 





n=842 χ2 P-value 
n (%) n (%) 
Years of age, n=5479 b 24.1±1.4 24±1.5 - 0.34 
Highest qualification, n=5303   6.47 0.04 
University degree or higher 2087 (46.5) 342 (42.0)   
High school/trade/diploma 2047 (45.6) 410 (50.4)   
Less than high school 355 (7.9) 62 (7.6)   
Marital status, n=5456   0.21 0.64 
Married/de facto 2247 (48.7) 415 (49.5)   
Not married/separated/widowed 2371 (51.3) 423 (50.5)   
Area of residence, n=5454     
Major cities 2421 (52.4) 452 (54.0) 1.63 0.44 
Inner regional 1392 (30.2) 234 (28.0)   
Outer regional/remote/very remote 804 (17.4) 151 (18.0)   
Ability to manage on income, 
n=4804 
  19.99 <0.001 
Easy 507 (12.5) 73 (9.9)   
Not too bad 1933 (47.6) 312 (42.1)   
Difficult sometimes 1305 (32.1) 274 (37.0)   
Difficult always/impossible 318 (7.8) 82 (11.1)   
Social support, n=5391   9.03 0.01 
All of the time 2818 (61.8) 467 (56.3)   
Most of the time 1196 (26.2) 243 (29.3)   
Some/a little/none of the time 548 (12.1) 119 (14.4)   
Age at menarche, n=5444   1.87 0.39 
8-11 years 544 (11.8) 111 (13.3)   
12-14 years 3504 (76.1) 620 (74.0)   
≥15 years 558 (12.1) 107 (12.8)   
BMI, n=5363   5.72 0.13 
Underweight (<18.5) 277 (6.1) 44 (5.4)   
Normal weight (18.5 to <25) 3039 (66.9) 526 (63.9)   
Overweight (25 to <30) 858 (18.9) 172 (20.9)   
Obese (≥30) 366 (8.1) 81 (9.8)   
Physical activity, n=5357   4.55 0.21 
Sedentary 361 (8.0) 80 (9.7)   
Low  1375 (30.3) 260 (31.6)   
Moderate  1128 (24.9) 202 (24.6)   
High  1671 (36.9) 280 (34.1)   
Smoking, n=5444   19.19 <0.001 
Never smoker 2794 (60.6) 446 (53.5)   
Ex-smoker 647 (14.0) 118 (14.2)   
Current smoker 1169 (25.4) 270 (32.4)   
OCPs use, n=5441   0.09 0.76 
Not using OCPs 1642 (35.6) 301 (36.2)   
Using OCPs 2967 (64.4) 531 (63.8)   
History of depression, n=5479   167.05 <0.001 
No  4200 (90.6) 631 (74.9)   
Yes 437 (9.4) 211 (25.1)   
a
 Percentages may not add up to 100% due to rounding. 
b Mean ± SD  
Table 2. Unadjusted and adjusted relative risks and 95% confidence intervals for the association of pre-pregnancy PMS and PPD (n=4586) 
PMS Crude RR Model 1 a Model 2 b Model 3 c Model 4 d 
Never Reference Reference Reference Reference Reference 
Rarely 1.05 (0.84-1.32) 1.05 (0.84-1.31) 1.01 (0.80-1.27) 1.01 (0.80-1.27) 1.03 (0.82-1.30) 
Sometimes 1.52 (1.27-1.83) 1.50 (1.25-1.80) 1.36 (1.13-1.64) 1.36 (1.13-1.64) 1.31 (1.09-1.57) 
Often 2.20 (1.77-2.74) 2.10 (1.68-2.62) 1.74 (1.39-2.17) 1.71 (1.37-2.13) 1.51 (1.22-1.87) 
a Model 1 adjusted for highest qualification, marital status, and ability to manage income 
b Model 2 adjusted for variables in Model 1 plus for maternal age, parity, gestational diabetes, preterm birth, pre-pregnancy BMI, physical activity, smoking and OCP use 
c Model 3 adjusted for variables in Model 2 plus for social support 
d Model 4 adjusted for variables in Model 3 plus for history of depression 
 
 
Table S1. Univariable analysis of the association between possible risk factors and PPD (n=5479) 
Variables  RR (95% CI) * P value 
Maternal age (continuous) 0.94 (0.93-0.96) <0.001 
Highest qualification  <0.001 
University degree or higher Reference  
High school/trade/diploma 1.44 (1.25-1.66)  
Less than high school 1.17 (0.88-1.56)  
Marital status  <0.001 
Married/de facto Reference  
Not married/separated/widowed 1.56 (1.28-1.88)  
Area of residence  0.94 
Major cities Reference  
Inner regional 1.02 (0.86-1.20)  
Outer regional/remote/very remote 0.98 (0.81-1.18)  
Ability to manage on income  <0.001 
Easy Reference  
Not too bad 1.02 (0.85-1.22)  
Difficult sometimes 1.30 (1.07-1.57)  
Difficult always/impossible 1.44 (1.12-1.86)  
Social support  0.01 
All of the time Reference  
Most of the time 1.05 (0.90-1.23)  
Some/a little/none of the time  1.41 (1.13-1.75)  
Age at menarche  0.24 
8-11 years 1.17 (0.96-1.41)  
12-14 years Reference  
≥15 years 1.09 (0.89-1.33)  
Premenstrual syndrome   <0.001 
Never Reference  
Rarely 0.97 (0.79-1.19)  
Sometimes 1.34 (1.14-1.59)  
Often 2.07 (1.71-2.52)  
Parity   <0.001 
Primiparous  Reference  
Multiparous 1.94 (1.71-2.20)  
Gestational diabetes  <0.001 
No  Reference  
Yes  1.57 (1.21-2.04)  
Premature birth  <0.001 
No  Reference  
Yes  1.73 (1.40-2.13)  
Body mass index (BMI)  0.01 
Underweight (<18.5) 0.97 (0.65-1.44)  
Normal weight (18.5 to <25) Reference  
Overweight (25 to <30) 1.26 (1.07-1.49)  
Obese (≥30) 1.29 (1.06-1.57)  
Physical activity  0.04 
Sedentary Reference  
Low  0.78 (0.63-0.97)  
Moderate  0.80 (0.64-1.01)  
High  0.94 (0.75-1.18)  
Smoking  <0.001 
Never smoker Reference  
Ex-smoker 1.25 (1.06-1.47)  
Current smoker 1.58 (1.33-1.89)  
OCPs use   0.12 
Not using OCPs Reference  
Using OCPs 1.12 (0.97-1.28)  
History of depression (doctor-diagnosed)  <0.001 
No  Reference  
Yes 2.49 (2.18-2.84)  
History of depression (treated with 
antidepressants) 
  
No  Reference <0.001 
Yes 2.04 (1.69-2.45)  
* Relative risk (95% confidence interval) 
 
Table S2. Summary of the association between pre-pregnancy PMS and PPD in sensitivity analyses a 
 
PMS 
Ever use of antidepressants inferring 
history of depression 
Multiple imputation for missing 
data b 
Inclusion of only primiparous women 
and their first births 
Adjusted RR* (n=4586) Adjusted RR* (n=5125) Adjusted RR* (n=3601) 
Never Reference Reference Reference  
Rarely 1.02 (0.81-1.28) 1.02 (0.83-1.26) 1.01 (0.76-1.33) 
Sometimes 1.33 (1.10-1.60) 1.28 (1.08-1.51) 1.15 (0.92-1.44) 
Often 1.64 (1.32-2.03) 1.65 (1.36-2.01) 1.53 (1.20-1.96) 
a Fully adjusted model, adjusting for highest qualification, marital status, ability to manage income, maternal age, parity, gestational diabetes, preterm birth, pre-pregnancy BMI, 
physical activity, smoking, OCP use, social support, and history of depression 
b Missing data was imputed for PMS, highest qualification, marital status, ability to manage income, pre-pregnancy BMI, physical activity, smoking, OCP use, and social support. 
* Relative Risk (95% Confidence Interval), calculated from Log-binomial model with generalized estimating equation 
 
Table S3. Association between pre-pregnancy PMS and PPD symptoms a (n=2375 b) 
PMS Adjusted Hazard Ratio *  
Never Reference  
Rarely 1.17 (0.79-1.76) 
Sometimes 0.89 (0.60-1.32) 
Often 1.75 (1.19-2.57) 
a Score of Mental Health Subscale in SF-36 ≤52 in the first postpartum year denoting PPD symptoms 
b Only women who filled out the Mental Health Subscale in the first postpartum year were included in analysis 
* Calculated from Cox proportional hazards model, which considered the time of the PPD symptoms since delivery, adjusting for highest qualification, marital status, ability to 
manage income, maternal age, parity, gestational diabetes, preterm birth, pre-pregnancy BMI, physical activity, smoking, OCP use, social support, and history of depression 
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Journal of Affective Disorders values your contribution and I look forward to receiving your 
revised manuscript.” 
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Thank you for the opportunity to revise our manuscript. We have undertaken a careful revision of 
the manuscript according to all comments received.  
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“This is a study with very large sample size. However, there are some issues to be addressed 
in the manuscript to make it looks more complete.” 
Response  
All questions raised have been addressed below and corresponding changes are highlighted in the 
main text. 
“Abstract -- The authors should provide the mean age of the subjects and define the definition 
of “rarely”, “sometimes”, and “often” since these are the major outcomes of this study.” 
Response  
The age ranges at baseline and the last wave of the 15-year follow-up are now given in the Abstract. 
“Never”, “rarely”, “sometimes”, and “often” are the pre-defined answers for a 4-category Likert-
scale reporting PMS experience in the last 12 months. These have been added to the Abstract (lines 
9-12). 
“Methods -- The authors should clarify the diagnostic validity of the question “In the last 12 
months, have you had premenstrual tension?” to diagnose PMS (Is PMT the same as PMS?... or 
Did all the subjects had been told about the definition of PMT/PMS before asking this 
question?)” 
Response  
We have reworded the description of how PMS was collected for clarity (Methods: pg. 3, lines 2-3). 
As no explanation was provided to participants about the definition of premenstrual tension, no 
further information was added regarding this in the text.  
The question asked in all ALSWH surveys between 2000 and 2015 was “In the last 12 months, have 
you had premenstrual tension?” “Premenstrual tension”, or “premenstrual tension syndrome”, is the 
term for PMS included in the International Classification of Diseases 10th revision (ICD-10) 1, 
which acknowledges the existence of the entity of PMS but provides no systematic criteria for 
diagnosis 2.  A consensus on the diagnosis and classification for PMS was not incorporated in the 
Royal College of Obstetrics and Gynaecology (RCOG) PMS guideline until 2017 3. Until this time 
there was a lack of universal agreement on the nature of PMS as well as a lack of universal 
acceptance of the criteria 4. We have previously published using the PMS measure 5-7.  
“As well as diagnosis of PPD --> How does the diagnostic validity of the questions “Were you 
diagnosed or treated for postnatal depression?” (yes/no). “In the last 3 or 4 years, have you 
been told by a doctor that you have postnatal depression?” (yes/no). Is PPD diagnosed by a 
psychiatrist, and how to differentiate from postpartum blues? --> The authors may explain in 
the context of postnatal service in Australia (e.g. every postpartum woman has to visit with a 
psychiatrist etc.)” 
Response 
In this paper, we have used administrative databases such as hospital admission records, 
Pharmaceutical Benefits Scheme prescriptions, and GP services to assess the accuracy of the self-
reported PPD (Discussion: pg. 7 lines 23-27). In addition, we also used postpartum depressive 
symptoms (yes/no) ascertained from the Mental Health Subscale of SF-36 as another measure for 
PPD in a sensitivity analysis (Discussion: pg.7 lines 28-33), which also generated similar results 
(see Table S3). 
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“This is a large sample study of the association of premenstrual syndrome (PMS) and 
postpartum depression (PPD). There are no diagnostic criteria both for PMS and PPD in the 
study, only according to the question” in the last 12 months have you had premenstrual 
tension?” for PMS, and using antidepressants after delivery for PPD. I think the diagnoses of 
PMS and PPD in this study are dubious and indeterminate. So the results of the study are 
uncertain, it will largely interfere the quality of the study. Therefore I consider that this 
manuscript is not suitable for the journal to publish and recommend the author to send the 
manuscript to another journal.” 
Response  
Please see our responses to questions from Reviewer #1.  
  
References  
1. World Health Organization. International Classification of Diseases, 10th Revision (ICD-10), 
2019 Edition. World Health Organization. https://icd.who.int/browse10/2019/en. 
Published 2019. Accessed 20 August, 2020. 
2. Freeman EW. PMS and diagnostic criteria. In: P. M. Shaughn O'Brien AR, Peter J. Schmidt, 
ed. The Premenstrual Syndromes: PMS and PMDD. 1st ed. London: CRC Press; 2007:9-20. 
3. Royal College of Obstetricians & Gynaecologists. Management of Premenstrual Syndrome: 
Green-top Guideline No. 48. BJOG. 2017;124(3):e73-e105. 
4. Halbreich U. The diagnosis of PMS/PMDD – the current debate. In: P. M. Shaughn O'Brien 
AR, Peter J. Schmidt, ed. The Premenstrual Syndromes: PMS and PMDD. 1st ed. London: 
CRC Press; 2007:9-20. 
5. Ju H, Jones M, Mishra GD. Premenstrual syndrome and dysmenorrhea: symptom 
trajectories over 13 years in young adults. Maturitas. 2014;78(2):99-105. 
6. Ju H, Jones M, Mishra GD. Illicit drug use, early age at first use and risk of premenstrual 
syndrome: A longitudinal study. Drug Alcohol Depend. 2015;152:209-217. 
7. Ju H. The magnitude, long-term trend and lifestyle risk factors of dysmenorrhea and 
premenstrual syndrome [PhD Thesis]: School of Public Health, The University of 
Queensland; 2016. 
 
 
